| Literature DB >> 21801617 |
Kate A Ward1, Paula J Spokes, Jeremy M McAnulty.
Abstract
We conducted a case-control study to identify risk factors for hospitalization from pandemic (H1N1) 2009 virus infection among persons >16 years of age in Sydney, Australia. The study comprised 302 case-patients and 603 controls. In a logistic regression model, after adjusting for age and sex, risk factors for hospitalization were pregnancy (odds ratio [OR] 22.4, 95% confidence interval [CI] 9.2-54.5), immune suppression (OR 5.5, 95% CI 2.8-10.9), pre-existing lung disease (OR 6.6, 95% CI 3.8-11.6), asthma requiring regular preventive medication (OR 4.3, 95% CI 2.7-6.8), heart disease (OR 2.3, 95% CI 1.2-4.1), diabetes (OR 3.8, 95% CI 2.2-6.5), and current smoker (OR 2.0, 95% CI 1.3-3.2) or previously smoked (OR 2.0, 95% CI 1.3-3.0). Although obesity was not independently associated with hospitalization, it was associated with an increased risk of requiring mechanical ventilation. Public health messages should give greater emphasis on the risk for severe disease among pregnant women and smokers.Entities:
Mesh:
Year: 2011 PMID: 21801617 PMCID: PMC3381572 DOI: 10.3201/eid1708.100842
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Comparison of characteristics for case-patients and controls in a study of risk for hospitalization because of pandemic (H1N1) 2009 influenza, Sydney, Australia, 2009*
| Variable | No. (%) case-patients, n = 302 | No. (%) controls, n = 603 | ||
| OR (95% CI) | p value | |||
| Sex | ||||
| F | 177 (59) | 396 (66) | Referent | |
| M | 125 (41) | 207 (34) | 1.4 (1.0–1.8) | 0.0379 |
| Age, y | ||||
| 16–25 | 40 ( | 61 ( | 2.4 (1.4–4.1) | |
| 26–35 | 54 ( | 92 ( | 2.1 (1.3–3.5) | |
| 36–45 | 58 ( | 111 ( | 1.9 (1.2–3.1) | |
| 46–55 | 72 ( | 111 ( | 2.3 (1.4–3.8) | |
| 56–65 | 44 ( | 105 ( | 1.5 (0.9–2.5) | |
| >65 | 34 ( | 123 ( | Referent | 0.007 |
| Area of residence in Sydney | ||||
| South East | 34 ( | 71 ( | ||
| West | 112 (37) | 229 (38) | ||
| South West | 123 (41) | 239 (40) | ||
| North | 33 ( | 64 ( |
|
|
| Aboriginal status | ||||
| Nonindigenous | 293 (97) | 596 (99) | Referent | |
| Indigenous | 9 ( | 7 ( | 2.6 (1–7.1) | 0.0591 |
| Body mass index† | ||||
| Underweight (<18.5) | 15 ( | 15 ( | 3.0 (1.4–6.5) | <0.0001 |
| Normal (18.5–24.9) | 85 ( | 259 (45) | Referent | |
| Overweight (25.0–29.9) | 77 ( | 175 ( | 1.3 (0.9–1.9) | |
| Obese 1 (30–34.9) | 51 ( | 79 ( | 2.0 (1.3–3.0) | |
| Obese 2 (35–39.9) | 31 ( | 29 ( | 3.3 (1.9–5.7) | |
| Obese 3 ( | 27 ( | 21 ( | 3.9 (2.1–7.3) |
|
| Concurrent conditions‡ | ||||
| Asthma | 114 (38) | 93 ( | ||
| No regular medication | 25 ( | 48 ( | 1.4 (0.8–2.4) | <0.0001 |
| Regular medication | 89 ( | 45 ( | 5.4 (3.6–8.0) | |
| Previous hospitalization | 48 ( | 24 ( | ||
| Heart disease§ | 40 ( | 41 ( | 2.1 (1.3–3.3) | 0.0016 |
| Heart failure | 8 ( | 1 ( | ||
| Angina | 10 ( | 7 ( | ||
| Heart attack | 8 ( | 9 ( | ||
| Congenital condition | 6 ( | 4 ( | ||
| Rheumatic fever | 6 ( | 1 ( | ||
| Kidney disease¶ | 10 ( | 8 ( | 2.5 (1.0–6.5) | 0.0522 |
| Renal failure | 5 (50) | 4 (50) | ||
| Dialysis | 3 ( | – | ||
| Transplant or waiting list | 4 (40) | – | ||
| Mental health problem | 53 ( | 49 ( | 2.4 (1.6–3.6) | <0.0001 |
| Neurologic problem | 24 ( | 42 ( | 1.2 (0.7–1.9) | 0.5925 |
| Immunosuppression | 30 ( | 22 ( | 2.9 (1.6–5.1) | 0.0002 |
| Obstructive sleep apnea | 37 ( | 23 ( | 3.5 (2.1–6.0) | <0.0001 |
| Lung disease | 58 ( | 31 ( | 4.4 (2.8–7.0) | <0.0001 |
| Regular medication | 39 (67) | 13 (42) | ||
| Previous hospitalization | 32 (55) | 11 (35) | ||
| Diabetes | 58 ( | 38 ( | 3.5 (2.3–5.5) | <0.0001 |
| Metabolic disorder | 3 ( | 7 ( | 0.9 (0.2–3.3) | 0.8204 |
| Liver disease | 23 ( | 20 ( | 2.4 (1.3–4.4) | 0.0053 |
| Blood disorder | 16 ( | 16 ( | 2.1 (1.0–4.2) | 0.0463 |
| Pregnancy | 40 ( | 7 ( | 13.0 (5.7–29.4) | <0.0001 |
| First trimester | 5 ( | 2 ( | ||
| Second trimester | 7 ( | 3 ( | ||
| Third trimester | 28 (70) | 2 ( |
|
|
| Smoking status# | ||||
| Nonsmoker | 144 (48) | 372 (62) | Referent | |
| Current smoker | 66 ( | 82 ( | 2.1 (1.4–3.0) | 0.0002 |
| Former smoker | 91 ( | 149 ( | 1.6 (1.1–2.2) |
|
| Influenza vaccine in 2009** | 107 (36) | 202 (34) | 1.1 (0.8–1.5) | 0.529 |
*OR, odds ratio; CI, confidence interval. †Groups are not mutually exclusive. ‡Body mass index calculated as weight in kilograms divided by height in meters squared. Data were missing for 16 case-patients and 25 controls. §Data were missing for 6 case-patients and 12 controls. ¶Data were missing for 2 controls. #Data were missing for 2 case-patients and 2 controls. **Vaccination information was missing for 2 case-patients and 1 control.
Independent risk factors for hospitalization from pandemic (H1N1) 2009 influenza, all case-patients and controls, Sydney, Australia, 2009*
| Patient characteristic | Adjusted OR (95% CI) | p value |
|---|---|---|
| Sex | ||
| F | Referent | |
| M | 1.8 (1.2–2.5) | 0.0017 |
| Age, y | ||
| 16–25 | 5.4 (2.5–11.4) | |
| 26–35 | 4.1 (2.0–8.3) | |
| 36–45 | 3.9 (2.0–7.6) | <0.0001 |
| 46–55 | 5.1 (2.7–9.6) | |
| 56–65 | 1.9 (1.0–2.5) | |
| >65 | Referent |
|
| Underlying condition | ||
| Asthma, regular medication | 4.3 (2.7–6.8) | <0.0001 |
| Heart disease | 2.3 (1.2–4.1) | 0.0083 |
| Immunosuppression | 5.5 (2.8–10.9) | <0.0001 |
| Lung disease | 6.6 (3.8–11.6) | <0.0001 |
| Diabetes | 3.8 (2.2–6.5) | <0.0001 |
| Pregnancy | 22.4 (9.2–54.5) | <0.0001 |
| Smoking status | ||
| Nonsmoker | Referent | |
| Current smoker | 2.0 (1.3–3.2) | 0.002 |
| Former smoker | 2.0 (1.3–3.0) |
|
| No. significant risk factors | ||
| 0 | Referent | |
| 1 | 3.9 (2.6–5.8) | |
| 2 | 9.3 (5.9–14.6) | <0.0001 |
| 3 | 20.4 (10.4–40.2) | |
|
| 80.3 (10.1–638.7) |
*OR, odds ratio; CI, confidence interval.
Risk factors for hospitalization caused by pandemic (H1N1) 2009 influenza for female case-patients and controls of childbearing age, Sydney, Australia, 2009*
| Patient characteristic | No. (%) case-patients, n = 99 | No. (%) controls, n = 181 | OR (95% CI) | p value | Adjusted OR (95% CI) | p value |
|---|---|---|---|---|---|---|
| Age, y | ||||||
| 16–25 | 28 (28) | 43 (24) | 1.4 (0.8–2.6) | |||
| 26–35 | 37 (37) | 64 (35) | 1.3 (0.7–2.2) | 0.5233 | ||
| 36–45 | 34 (34) | 74 (41) | Referent |
|
|
|
| Aboriginal status | ||||||
| Nonindigenous | 95 (98) | 177 (96) | Referent | 0.3864 | ||
| Indigenous | 4 (4) | 4 (2) | 1.9 (0.5–7.6) |
|
|
|
| Body mass index† | ||||||
| Underweight (<18.5) | 8 (9) | 9 (5) | 2.8 (1.0–8.0) | |||
| Normal (18.5–24.9) | 31 (33) | 99 (57) | Referent | |||
| Overweight (25.0–29.9) | 15 (16) | 35 (20) | 1.4 (0.7–2.8) | 0.0003 | ||
| Obese 1 (30.0–34.9) | 17 (18) | 18 (10) | 3.0 (1.4–6.6) | |||
| Obese 2 (35.0–39.9) | 10 (11) | 4 (2) | 8.0 (2.3–27.3) | |||
| Obese 3 (>40) | 12 (13) | 8 (5) | 4.8 (1.8–12.8) |
|
|
|
| Health condition‡ | ||||||
| Asthma | 46 (46) | 35 (19) | Referent | |||
| No regular medication | 7 (7) | 21 (12) | 0.9 (0.4–2.3) | <0.001 | 10 (4.0–21.0) | <0.0001 |
| Regular medication | 39 (39) | 14 (8) | 7.7 (3.9–15.3) | |||
| Heart disease§ | 0 | 1 (0.5) | <0.001 | 0.9871 | ||
| Kidney disease | 0 | 1 (0.5) | <0.001 | 0.987 | ||
| Mental health problem | 17 (17) | 19 (11) | 1.8 (0.9–3.6) | 0.1139 | ||
| Neurologic problem | 4 (4) | 8 (4) | 0.9 (0.3–3.1) | 0.8809 | ||
| Immunosupression | 1 (1) | 2 (1) | 0.9 (0.1–10.2) | 0.942 | ||
| Obstructive sleep apnea | 10 (10) | 4 (2) | 5.0 (1.5–16.3) | 0.0081 | ||
| Lung disease | 10 (10) | 4 (2) | 5.0 (1.5–16.3) | 0.0081 | 7 (2.0–28.0) | 0.0043 |
| Diabetes | 14 (14) | 2 (1) | 14.7 (3.3–66.3) | 0.0005 | 20 (4.0–103.0) | 0.0003 |
| Metabolic disorder | 1 (1) | 2 (1) | 0.9 (0.1–10.2) | 0.942 | ||
| Liver disease | 5 (5) | 0 | >999.9 | 0.9798 | ||
| Blood disorder | 4 (4) | 8 (4) | 0.9 (0.3–3.1) | 0.8809 | ||
| Pregnancy | 40 (40) | 7 (4) | 16.9 (7.2–39.6) | <0.001 | 28 (11.0–70.0) | <0.0001 |
| Smoking status | ||||||
| Nonsmoker | 53 (54) | 130 (72) | Referent | |||
| Current smoker | 24 (24) | 32 (18) | 1.8 (1.0–3.4) | 0.0057 | ||
| Former smoker | 22 (22) | 19 (11) | 2.8 (1.4–5.7) |
|
|
|
| Influenza vaccine in 2009¶ | 20 (20) | 30 (17) | 1.3 (0.7–2.4) | 0.4262 |
*OR, odds ratio; CI, confidence interval. †8 controls and 6 case-patients missing data. ‡Groups are not mutually exclusive. §1 control and 3 case-patients missing data. ¶1 case-patient missing data.
Risk factors for mechanical ventilation because of pandemic (H1N1) 2009 infection, Sydney, Australia, 2009*
| Patient characteristic | No. (%) case-patients, n = 37 | No. (%) controls, n = 603 | OR (95% CI) | p value | Adjusted OR (95% CI) | p value |
| Sex | ||||||
| M | 11 (30) | 207 (34) | ||||
| F | 26 (70) | 396 (66) | 1.2 (0.6–2.6) | 0.5674 |
|
|
| Age, y | ||||||
| 16–25 | 3 (8) | 61 (10) | 3.7 (0.7–19) | 5.5 (0.7–42.0) | ||
| 26–35 | 11 (30) | 92 (15) | 9.1 (2.5–33.3) | 12.2 (2.5–58.2) | ||
| 36–45 | 12 (32) | 111 (18) | 8.2 (2.3–29.7) | 10.4 (2.3–48.3) | ||
| 46–55 | 8 (22) | 111 (18) | 5.5 (1.4–21.0) | 10.2 (2.3–45.9) | ||
| >55 | 3 (8) | 228 (38) |
| 0.0114 |
| 0.0176 |
| Aboriginal status | ||||||
| Nonindigenous | 36 (97) | 596 (99) | ||||
| Indigenous | 1 (3) | 7 (1) | 2.4 (0.3–19.7) | 0.426 |
|
|
| Body mass index† | ||||||
| Underweight (<18.5) | 3 (9) | 15 (3) | 8.6 (2.0–37.9) | 10.6 (1.9–58.9) | ||
| Normal (18.5–24.9) | 6 (17) | 259 (45) | 0.0004 | 0.0022 | ||
| Overweight (25.0–29.9) | 10 (29) | 175 (30) | 2.5 (0.9–6.9) | 3.2 (1.0–10.3) | ||
| Obese 1 (30.0–34.9) | 5 (14) | 79 (14) | 2.7 (0.8–9.2) | 1.8 (0.5–7.4) | ||
| Obese 2 (35.0–39.9) | 5 (14) | 29 (5) | 7.4 (2.1–25.9) | 9.8 (2.4–40.1) | ||
| Obese 3 (>40) | 6 (17) | 21 (4) | 12.3 (3.7–41.6) |
| 11.6 (2.7–49.3) |
|
| Health condition‡ | ||||||
| Asthma | 13 (65) | 93 (15) | ||||
| No regular medication | 5 (14) | 48 (8) | 2.2 (0.8–6.1) | 0.0061 | ||
| Regular medication | 8 (22) | 45 (7) | 3.8 (1.6–8.9) | |||
| Heart disease§ | 3 (9) | 41 (7) | 1.3 (0.4–4.3) | 0.7136 | ||
| Kidney disease¶ | 1 (3) | 8 (1) | 2.1 (0.3–16.9) | 0.5013 | ||
| Mental health problem | 6 (16) | 49 (8) | 2.2 (0.9–5.5) | 0.0958 | ||
| Neurologic problem | 3 (8) | 42 (7) | 1.2 (0.3–4.0) | 0.792 | ||
| Immunosuppression | 1 (3) | 22 (4) | 0.7 (0.1–5.6) | 0.7655 | ||
| Obstructive sleep apnea | 2 (5) | 23 (4) | 1.4 (0.3–6.4) | 0.6296 | ||
| Lung disease | 6 (16) | 31 (5) | 3.6 (1.4–9.2) | 0.0084 | 8.6 (2.6–28.5) | 0.0005 |
| Diabetes | 5 (14) | 38 (6) | 2.3 (0.9–6.3) | 0.0977 | 4.4 (1.2–15.6) | 0.0383 |
| Liver disease | 2 (5) | 20 (3) | 1.7 (0.4–7.4) | 0.503 | ||
| Pregnancy | 8 (22) | 7 (1) | 23.4 (8.0–69.2) | <0.001 | 40.5 (9.7–168.1) | <0.0001 |
| Smoking status | ||||||
| Nonsmoker | 17 (46) | 372 (62) | 2.4 (1.0–5.5) | 0.0325 | ||
| Current or former smoker | 20 (54) | 231 (38) | 1.9 (1.0–3.7) | 0.0605 |
|
|
| Influenza vaccine in 2009 | 20 (54) | 202 (34) | 0.3 (0.1–0.8) | 0.0163 |
*OR, odds ratio; CI, confidence interval. †Data missing for 2 case-patients and 25 controls. ‡Groups are not mutually exclusive. §Date missing for 2 case-patients and 12 controls. ¶Data missing for 3 controls.
Comparison of characteristics of patients with cases of pandemic (H1N1) 2009 influenza by time from symptom onset to medical attention, Sydney, Australia, 2009*
| Patient characteristic | Medical attention within 48 h | OR (95% CI) | p value | |
|---|---|---|---|---|
| Yes, no. (%) patients, n = 235 | No, no. (%) patients, n = 60 | |||
| Sex | ||||
| M | 97 (41) | 24 (40) | ||
| F | 138 (59) | 36 (60) | 1.1 (0.6–1.9) | 0.8576 |
| Age, y | ||||
| 16–25 | 33 (14) | 5 (8) | 1.1 (0.3–4.3) | |
| 26–35 | 44 (19) | 9 (15) | 0.8 (0.3–2.8) | |
| 36–45 | 47 (20) | 11 (18) | 0.7 (0.2–2.3) | |
| 46–55 | 50 (21) | 20 (33) | 0.4 (0.1–1.3) | |
| 56–65 | 32 (14) | 10 (17) | 0.6 (0.2–1.8) | |
| >65 | 29 (12) | 5 (8) |
| 0.3677 |
| Aboriginal status | ||||
| Nonindigenous | 229 (97) | 58 (97) | 0.7409 | |
| Indigenous | 6 (3) | 2 (3) | 0.8 (0.1–3.9) |
|
| Body mass index† | ||||
| Underweight (<18.5) | 13 (6) | 2 (3) | 1.6 (0.3–7.8) | |
| Normal (18.5–24.9) | 65 (28) | 16 (27) | 0.4457 | |
| Overweight (25.0–29.9) | 67 (29) | 10 (17) | 1.6 (0.7–3.9) | |
| Obese 1 (30–34.9) | 38 (16) | 12 (20) | 0.8 (0.3–1.8) | |
| Obese 2 (35–39.9) | 23 (10) | 6 (10) | 0.9 (0.3–2.7) | |
| Obese 3 (>40) | 19 (8) | 8 (13) | 0.6 (0.2–1.6) |
|
| Health condition‡ | ||||
| Asthma | 89 (38) | 24 (40) | 0.3607 | |
| No regular medication | 16 (7) | 9 (15) | ||
| Regular medication | 73 (31) | 15 (25) | 1.4 (0.7–2.6) | |
| Heart disease§ | 31 (13) | 7 (12) | 1.2 (0.5–2.8) | 0.703 |
| Kidney disease | 8 (3) | 2 (3) | 1.0 (0.2–4.9) | 0.9785 |
| Mental health problem | 34 (14) | 17 (28) | 0.4 (0.2–0.8) | 0.0129 |
| Neurologic problem | 14 (6) | 8 (13) | 0.4 (0.2–1.0) | 0.0586 |
| Immunosuppression | 22 (9) | 6 (10) | 0.9 (0.4–2.4) | 0.8803 |
| Obstructive sleep apnea | 26 (11) | 10 (17) | 0.6 (0.3–1.4) | 0.2399 |
| Lung disease | 46 (20) | 11 (18) | 1.1 (0.5–2.2) | 0.828 |
| Diabetes | 48 (20) | 10 (17) | 1.3 (0.6–2.7) | 0.5141 |
| Liver disease | 16 (7) | 5 (8) | 0.8 (0.3–2.3) | 0.6823 |
| Pregnancy | 33 (14) | 7 (12) | 1.3 (0.5–3.2) | 0.6008 |
| Smoking status¶ | ||||
| Nonsmoker | 113 (48) | 26 (43) | ||
| Current or former smoker | 121 (51) | 34 (57) | 0.8 (0.5–1.5) | 0.493 |
| Influenza vaccine in 2009# | 86 (37) | 19 (32) | 1.3 (0.7–2.3) | 0.4507 |
*OR, odds ratio; CI, confidence interval. †Data missing for 10 case-patients who received medical attention within 48 h and 6 who did not. ‡Groups are not mutually exclusive. §Data were missing for 6 case-patients who received medical attention within 48 h. ¶Data were missing for 1 case-patient who received medical attention within 48 h. #Vaccination information was missing for 2 case-patients and 1 control.